Clinical trials of 2-methyl-3 thiapentamethylene-1:5-bis (tri-methylammonium iodide): a potent ganglion-blocking agent.
D064751:Ammonium Compounds / Q000494:pharmacology*; D001337:Autonomic Agents / Q000494:pharmacology*; D005730:Ganglionic Blockers; D007454:Iodides; D008744:Methylamines
D064751:Ammonium Compounds; D001337:Autonomic Agents; D005730:Ganglionic Blockers; D007454:Iodides; D008744:Methylamines; C027451:methylamine
AMMONIUM COMPOUNDS/effects; AUTONOMIC DRUGS/effects